Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of Intestinal Diseases
2017-07-01
|
| Series: | Intestinal Research |
| Online Access: | https://doi.org/10.5217/ir.2017.15.3.263 |